Adverse Event Clinical Research
1.0.1 - STU1
Adverse Event Clinical Research
1.0.1 - STU1
This page is part of the Adverse Event Clinical Research (v1.0.1: STU 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions
| Page standards status: Informative |
{
"resourceType" : "MedicationAdministration",
"id" : "medicationAdministration-for-bresentrik",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicationAdministration</b><a name=\"medicationAdministration-for-bresentrik\"> </a><a name=\"hcmedicationAdministration-for-bresentrik\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicationAdministration "medicationAdministration-for-bresentrik" </p></div><p><b>status</b>: completed</p><h3>Medications</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Reference</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"Medication-bresentrik.html\">Medication/bresentrik</a></td></tr></table><p><b>subject</b>: <a href=\"Patient-JanetPatient.html\">Patient/JanetPatient: Janet</a> " CLINICAL TRIAL PATIENT"</p><p><b>encounter</b>: <span>: Reference(Encounter/f001) encounter which leads to this prescription</span></p><p><b>occurence</b>: 2023-04-05 14:30:00+0100 --> 2023-04-07 14:30:00+0100</p><blockquote><p><b>performer</b></p><h3>Actors</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Reference</b></td></tr><tr><td style=\"display: none\">*</td><td><span>: Reference(http://a.fhir.server/svc/StructureDefinition/c8973a22-2b5b-4e76-9c66-00639c99e61b) Patrick Pump</span></td></tr></table></blockquote><h3>Reasons</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>Given as Ordered <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-reason-medication-given.html\">Reason Medication Given Codes</a>#b)</span></td></tr></table><p><b>request</b>: <a href=\"MedicationRequest-medicationrequest-for-bresentrik.html\">MedicationRequest/medicationrequest-for-bresentrik</a></p><h3>Dosages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Text</b></td><td><b>Route</b></td><td><b>Dose</b></td></tr><tr><td style=\"display: none\">*</td><td>6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count. With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL</td><td>Oral route (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#26643006)</span></td><td>6 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span></td></tr></table><p><b>eventHistory</b>: <a name=\"hcsignature-medicationAdministration-bresentrik\"> </a></p><blockquote><p/><p><a name=\"signature-medicationAdministration-bresentrik\"> </a></p><p><a name=\"hcsignature-medicationAdministration-bresentrik\"> </a></p><p><b>target</b>: <span>: Reference(ServiceRequest/oncology321)</span></p><p><b>recorded</b>: Apr 5, 2023, 5:23:07 PM</p><h3>Agents</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Role</b></td><td><b>Who</b></td></tr><tr><td style=\"display: none\">*</td><td>author (originator) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-v3-ParticipationType.html\">ParticipationType</a>#AUT)</span></td><td><span>: Reference(Practitioner/example) Dr Adam Careful</span></td></tr></table><h3>Signatures</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>When</b></td><td><b>Who</b></td><td><b>TargetFormat</b></td><td><b>SigFormat</b></td><td><b>Data</b></td></tr><tr><td style=\"display: none\">*</td><td>Author's Signature (Details: urn:iso-astm:E1762-95:2013 code 1.2.840.10065.1.12.1.1 = 'Author's Signature', stated as 'Author's Signature')</td><td>Apr 5, 2023, 5:23:07 PM</td><td><span>: Reference(Practitioner/example) Dr Adam Careful</span></td><td>application/fhir+xml</td><td>application/signature+xml</td><td>(base64 data - 20 bytes)</td></tr></table></blockquote><hr/><blockquote><p><b>Generated Narrative: Provenance #signature-medicationAdministration-bresentrik</b><a name=\"signature-medicationAdministration-bresentrik\"> </a><a name=\"hcsignature-medicationAdministration-bresentrik\"> </a></p><p><b>target</b>: <span>: Reference(ServiceRequest/oncology321)</span></p><p><b>recorded</b>: Apr 5, 2023, 5:23:07 PM</p><h3>Agents</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Role</b></td><td><b>Who</b></td></tr><tr><td style=\"display: none\">*</td><td>author (originator) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-v3-ParticipationType.html\">ParticipationType</a>#AUT)</span></td><td><span>: Reference(Practitioner/example) Dr Adam Careful</span></td></tr></table><h3>Signatures</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>When</b></td><td><b>Who</b></td><td><b>TargetFormat</b></td><td><b>SigFormat</b></td><td><b>Data</b></td></tr><tr><td style=\"display: none\">*</td><td>Author's Signature (Details: urn:iso-astm:E1762-95:2013 code 1.2.840.10065.1.12.1.1 = 'Author's Signature', stated as 'Author's Signature')</td><td>Apr 5, 2023, 5:23:07 PM</td><td><span>: Reference(Practitioner/example) Dr Adam Careful</span></td><td>application/fhir+xml</td><td>application/signature+xml</td><td>(base64 data - 20 bytes)</td></tr></table></blockquote></div>"
},
"contained" : [
{
"resourceType" : "Provenance",
"id" : "signature-medicationAdministration-bresentrik",
"target" : [
{
"identifier" : {
"system" : "http://hospital2.org/",
"value" : "oncology321"
},
"display" : "Reference(ServiceRequest/oncology321)"
}
],
"recorded" : "2023-04-05T17:23:07Z",
"agent" : [
{
"role" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ParticipationType",
"code" : "AUT"
}
]
}
],
"who" : {
"display" : "Reference(Practitioner/example) Dr Adam Careful"
}
}
],
"signature" : [
{
"type" : [
{
"system" : "urn:iso-astm:E1762-95:2013",
"code" : "1.2.840.10065.1.12.1.1",
"display" : "Author's Signature"
}
],
"when" : "2023-04-05T17:23:07Z",
"who" : {
"identifier" : {
"system" : "http://hospital.org/",
"value" : "DrAdamCareful"
},
"display" : "Reference(Practitioner/example) Dr Adam Careful"
},
"targetFormat" : "application/fhir+xml",
"sigFormat" : "application/signature+xml",
"data" : "dGhpcyBibG9iIGlzIHNuaXBwZWQ="
}
]
}
],
"status" : "completed",
"medication" : {
"reference" : {
🔗 "reference" : "Medication/bresentrik"
}
},
"subject" : {
🔗 "reference" : "Patient/JanetPatient",
"display" : "Janet"
},
"encounter" : {
"identifier" : {
"system" : "http://hospitalNumber2",
"value" : "f001"
},
"display" : "Reference(Encounter/f001) encounter which leads to this prescription"
},
"occurencePeriod" : {
"start" : "2023-04-05T14:30:00+01:00",
"end" : "2023-04-07T14:30:00+01:00"
},
"performer" : [
{
"actor" : {
"reference" : {
"identifier" : {
"system" : "http://a.fhir.server/svc/StructureDefinition/",
"value" : "c8973a22-2b5b-4e76-9c66-00639c99e61b"
},
"display" : "Reference(http://a.fhir.server/svc/StructureDefinition/c8973a22-2b5b-4e76-9c66-00639c99e61b) Patrick Pump"
}
}
}
],
"reason" : [
{
"concept" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/reason-medication-given",
"code" : "b",
"display" : "Given as Ordered"
}
]
}
}
],
"request" : {
🔗 "reference" : "MedicationRequest/medicationrequest-for-bresentrik"
},
"dosage" : {
"text" : "6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count. With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL",
"route" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "26643006",
"display" : "Oral route (qualifier value)"
}
]
},
"dose" : {
"value" : 6,
"unit" : "mg",
"system" : "http://unitsofmeasure.org",
"code" : "mg"
}
},
"eventHistory" : [
{
"reference" : "#signature-medicationAdministration-bresentrik",
"display" : "Author's Signature"
}
]
}
IG © 2020+ HL7 International / Biomedical Research and Regulation. Package hl7.fhir.uv.ae-research-ig#1.0.1 based on FHIR 5.0.0. Generated 2024-04-30
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change